vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Summit Hotel Properties, Inc. (INN). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $185.1M, roughly 1.4× Summit Hotel Properties, Inc.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 1.4% vs -5.6%, a 7.0% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs 0.3%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -2.3%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
The Ritz-Carlton Hotel Company, LLC is an American multinational company that operates the luxury hotel chain known as The Ritz-Carlton. The company has 108 luxury hotels and resorts in 30 countries and territories with 29,158 rooms, in addition to 46 hotels with 8,755 rooms planned for the future.
ACAD vs INN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $185.1M |
| Net Profit | $3.6M | $-10.4M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 7.6% |
| Net Margin | 1.4% | -5.6% |
| Revenue YoY | 9.7% | 0.3% |
| Net Profit YoY | — | -122.9% |
| EPS (diluted) | $0.02 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $185.1M | ||
| Q4 25 | $284.0M | $175.0M | ||
| Q3 25 | $278.6M | $177.1M | ||
| Q2 25 | $264.6M | $192.9M | ||
| Q1 25 | $244.3M | $184.5M | ||
| Q4 24 | $259.6M | $172.9M | ||
| Q3 24 | $250.4M | $176.8M | ||
| Q2 24 | $242.0M | $193.9M |
| Q1 26 | $3.6M | $-10.4M | ||
| Q4 25 | $273.6M | $-2.6M | ||
| Q3 25 | $71.8M | $-11.8M | ||
| Q2 25 | $26.7M | $2.0M | ||
| Q1 25 | $19.0M | $623.0K | ||
| Q4 24 | $143.7M | $916.0K | ||
| Q3 24 | $32.8M | $-3.6M | ||
| Q2 24 | $33.4M | $38.7M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | 7.6% | ||
| Q4 25 | 6.1% | 8.3% | ||
| Q3 25 | 12.8% | 4.8% | ||
| Q2 25 | 12.2% | 11.8% | ||
| Q1 25 | 7.9% | 10.7% | ||
| Q4 24 | 59.1% | 4.6% | ||
| Q3 24 | 12.6% | 8.9% | ||
| Q2 24 | 12.6% | 29.0% |
| Q1 26 | 1.4% | -5.6% | ||
| Q4 25 | 96.3% | -1.5% | ||
| Q3 25 | 25.8% | -6.6% | ||
| Q2 25 | 10.1% | 1.1% | ||
| Q1 25 | 7.8% | 0.3% | ||
| Q4 24 | 55.4% | 0.5% | ||
| Q3 24 | 13.1% | -2.0% | ||
| Q2 24 | 13.8% | 20.0% |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | $-0.05 | ||
| Q3 25 | $0.42 | $-0.11 | ||
| Q2 25 | $0.16 | $-0.02 | ||
| Q1 25 | $0.11 | $-0.04 | ||
| Q4 24 | $0.86 | $0.05 | ||
| Q3 24 | $0.20 | $-0.04 | ||
| Q2 24 | $0.20 | $0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $44.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $840.4M |
| Total Assets | $1.6B | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $44.8M | ||
| Q4 25 | $177.7M | $36.1M | ||
| Q3 25 | $258.0M | $41.1M | ||
| Q2 25 | $253.6M | $39.5M | ||
| Q1 25 | $217.7M | $48.2M | ||
| Q4 24 | $319.6M | $40.6M | ||
| Q3 24 | $155.1M | $51.7M | ||
| Q2 24 | $177.1M | $45.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B |
| Q1 26 | — | $840.4M | ||
| Q4 25 | $1.2B | $862.2M | ||
| Q3 25 | $917.3M | $875.8M | ||
| Q2 25 | $822.4M | $895.1M | ||
| Q1 25 | $765.2M | $920.4M | ||
| Q4 24 | $732.8M | $909.5M | ||
| Q3 24 | $577.2M | $911.4M | ||
| Q2 24 | $516.7M | $931.9M |
| Q1 26 | $1.6B | $2.8B | ||
| Q4 25 | $1.6B | $2.8B | ||
| Q3 25 | $1.3B | $2.8B | ||
| Q2 25 | $1.2B | $2.9B | ||
| Q1 25 | $1.1B | $2.9B | ||
| Q4 24 | $1.2B | $2.9B | ||
| Q3 24 | $976.9M | $2.8B | ||
| Q2 24 | $914.1M | $2.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.62× | ||
| Q3 25 | — | 1.62× | ||
| Q2 25 | — | 1.59× | ||
| Q1 25 | — | 1.54× | ||
| Q4 24 | — | 1.54× | ||
| Q3 24 | — | 1.47× | ||
| Q2 24 | — | 1.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
Segment breakdown not available.
INN
| Pro forma room revenue | $162.1M | 88% |
| Pro forma other hotel operations revenue | $22.4M | 12% |
